August 31, 2021
Santen Pharmaceutical said on August 30 that it has filed a new drug application in Japan for STN1008903, an upgraded version of Diquas (diquafosol sodium), for the treatment of dry eye. STN1008903 was developed to reduce the frequency of administration...read more